Used as a key intermediate in the synthesis of antidiabetic drugs, particularly DPP-4 inhibitors for type 2 diabetes treatment. Its structure enables high selectivity and potency in enzyme inhibition, improving glycemic control. Commonly employed in pharmaceutical research to develop orally active agents with enhanced metabolic stability and bioavailability. Also utilized in structure-activity relationship studies to optimize drug candidates targeting incretin hormone regulation.